Evidence map›Paper›PMID 30279488›Full record

ArticleScientific reports2018

A phage-based assay for the rapid, quantitative, and single CFU visualization of E. coli (ECOR #13) in drinking water.

Troy C Hinkley, Sangita Singh, Spencer Garing, Anne-Laure M Le Ny, Kevin P Nichols, Joseph E Peters, Joey N Talbert, Sam R Nugen

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. ACS applied bio materials · 2022
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. The Many Applications of Engineered Bacteriophages-An Overview.Pharmaceuticals (Basel, Switzerland) · 2021
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Application of Bacteriophages in Nanotechnology.Nanomaterials (Basel, Switzerland) · 2020
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Troy C HinkleyDepartment of Food Science, Cornell University, Ithaca, NY, 14853, United States.
Sangita SinghDepartment of Food Science and Human Nutrition, Iowa State University, Ames, IA, 50011, United States.
Spencer GaringIntellectual Ventures Laboratory/Global Good, Bellevue, WA, 98007, United States.
Anne-Laure M Le NyIntellectual Ventures Laboratory/Global Good, Bellevue, WA, 98007, United States.
Kevin P NicholsIntellectual Ventures Laboratory/Global Good, Bellevue, WA, 98007, United States.
Joseph E PetersDepartment of Microbiology, Cornell University, Ithaca, NY, 14853, United States.
Joey N TalbertDepartment of Food Science and Human Nutrition, Iowa State University, Ames, IA, 50011, United States.
Sam R NugenDepartment of Food Science, Cornell University, Ithaca, NY, 14853, United States. snugen@cornell.edu.ORCID http://orcid.org/0000-0003-3638-1776
Bellevue Hospital Center · USCornell University · USIowa State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drinking water standards in the United States mandate a zero tolerance of generic E. coli in 100 mL of water. The presence of E. coli in drinking water indicates that favorable environmental conditions exist that could have resulted in pathogen contamination. Therefore, the rapid and specific enumeration of E. coli in contaminated drinking water is critical to mitigate significant risks to public health. To meet this challenge, we developed a bacteriophage-based membrane filtration assay that employs novel fusion reporter enzymes to fully quantify E. coli in less than half the time required for traditional enrichment assays. A luciferase and an alkaline phosphatase, both specifically engineered for increased enzymatic activity, were selected as reporter probes due to their strong signal, small size, and low background. The genes for the reporter enzymes were fused to genes for carbohydrate binding modules specific to cellulose. These constructs were then inserted into the E. coli-specific phage T7 which were used to infect E. coli trapped on a cellulose filter. During the infection, the reporters were expressed and released from the bacterial cells following the lytic infection cycle. The binding modules facilitated the immobilization of the reporter probes on the cellulose filter in proximity to the lysed cells. Following substrate addition, the location and quantification of E. coli cells could then be determined visually or using bioluminescence imaging for the alkaline phosphatase and luciferase reporters, respectively. As a result, a detection assay capable of quantitatively detecting E. coli in drinking water with similar results to established methods, but less than half the assay time was developed.

Indexed as

Bacteriophage T7Alkaline PhosphataseColony Count, MicrobialDrinking WaterEscherichia coliFiltrationGenetic EngineeringLuciferasesWaterborne DiseasesWater QualityAlkaline PhosphataseDrinking WaterLuciferases

Identifiers

PMID30279488
PMCPMC6168599
OpenAlexW2892608643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.